DELCATH SYSTEMS, INC.·4

May 14, 5:45 PM ET

SALAMON STEVEN A J 4

4 · DELCATH SYSTEMS, INC. · Filed May 14, 2026

Research Summary

AI-generated summary of this filing

Updated

Delcath (DCTH) Director Steven Salamon Receives 22,500-Share Award

What Happened

  • Steven A. J. Salamon, a director of Delcath Systems, Inc. (DCTH), received a grant reported on 2026-05-13 of 22,500 derivative shares (an option/award) at a $0.00 price. The reported acquisition value is $0. This is an award/grant (not a sale or open-market purchase).

Key Details

  • Transaction date: 2026-05-13; Filing date: 2026-05-14 (timely filing).
  • Type: Grant / Award (derivative); Amount: 22,500 shares; Price shown: $0.00.
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnote: The option vests at one-twelfth (1/12) per month starting May 13, 2026 while the reporting person remains a director. The option expires the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.
  • No indication this was an immediate exercise or sale (no cashless exercise or disposition reported).

Context

  • This is an equity award (derivative/option) granted to a director and should be viewed as a compensation/retention-type award rather than an open-market purchase or insider sale. It does not generate immediate proceeds and does not by itself indicate the director bought or sold shares.

Insider Transaction Report

Form 4
Period: 2026-05-13
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-05-13+22,50022,500 total
    Exercise: $11.61Common Stock (22,500 underlying)
Footnotes (1)
  • [F1]The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.
Signature
/s/ Gerard Michel, Attorney-in-Fact|2026-05-14

Documents

1 file
  • 4
    form4-05142026_050503.xmlPrimary